Deutsche Tageszeitung - Measles cases soar in Europe: WHO

Measles cases soar in Europe: WHO


Measles cases soar in Europe: WHO
Measles cases soar in Europe: WHO / Photo: © AFP

Measles cases soared in Europe in 2023 to 42,200, a nearly 45-fold increase over the previous year, the UN health agency said on Tuesday, calling for urgent vaccination efforts to halt the spread.

Change text size:

Some 41 countries out of 53 the World Health Organization includes in its Europe region reported the infectious disease, WHO said. In 2022, 941 cases were registered.

Vaccination rates against the disease slipped during the Covid-19 pandemic and "urgent vaccination efforts are needed to halt transmission and prevent further spread".

Russia and Kazakhstan fared the worst, with 10,000 cases each from January to October last year. In Western Europe, Britain had the most cases with 183.

The WHO also said there were nearly 21,000 hospitalisations and five measles-related deaths in the Januaryu-October period. "This is concerning," WHO said.

Some 1.8 million infants in the WHO's Europe region were not vaccinated against measles between 2020 and 2022.

"It is vital that all countries are prepared to rapidly detect and timely respond to measles outbreaks, which could endanger progress towards measles elimination."

- Falling vaccinations -

Measles is caused by a virus and spreads easily when people breathe, cough or sneeze. It is most common in children, but can affect anyone.

Symptoms often include a rash, running nose, cough and watery eyes. Complications can be severe.

Measles vaccinations consist of two shots, usually one at nine months of age and the second at 15-18 months. The vaccine is often given along with one for mumps and rubella and known as MMR.

At least 95 percent of children need to be fully vaccinated against the disease in a locality to prevent outbreaks.

Vaccination rates against measles have been dropping across the globe.

In 2022, 83 percent of children received a first measles vaccine during their first year of life, up from 81-percent coverage in 2021, but down from 86 percent before the pandemic and the lowest level since 2008, WHO has said previously.

In 2022, only 92 percent of children in Europe received a second dose of the vaccine, according to WHO.

In Britain, in some areas around the major city of Birmingham the level of full vaccination has dropped to 81 percent.

In 2021, there were an estimated 128,000 measles deaths worldwide, mostly among under-vaccinated or unvaccinated children under five, it said.

WHO estimates that measles vaccines have helped prevent 56 million deaths between 2000 and 2021.

(L.Møller--DTZ)

Featured

RCSI President Calls for Enhanced Surgical Research Support at Millin Meeting

Professor Michael Kerin, president of the Royal College of Surgeons in Ireland (RCSI), has called for increased support for surgeons to strengthen the nation's surgical research capacity. His remarks preceded the annual Millin Meeting, a gathering of leading healthcare experts focused on integrating innovation and clinical trials into everyday surgical practice.

Toddler Diagnosed With Leukemia After Symptoms Dismissed as Winter Illness

Manraj Singh Hans, now seven, was diagnosed with acute lymphoblastic leukemia in February 2023 after a prolonged period during which his early symptoms were repeatedly misdiagnosed as common infections. His parents, Narinder Singh and Parm Hans, initially dismissed signs of illness as winter fatigue before blood in the child’s diaper prompted urgent medical intervention.

American Airlines passenger falls ill and vomits on three travellers

A passenger on board an American Airlines reportedly experienced a medical episode mid-flight A morning flight from Philadelphia to Miami was thrown into disarray after a passenger reportedly vomited over three other travellers.

iPS Cell Research Accelerates Drug Discovery for ALS and Spinal Cord Injury

Researchers at Keiō University are leveraging induced pluripotent stem (iPS) cells to accelerate drug discovery for rare neurological conditions. Director Okano Hideyuki reports that human-derived cell models have enabled the rapid identification of potential treatments for amyotrophic lateral sclerosis and paved the way for regenerative therapies targeting spinal cord injuries.

Change text size: